Iovance Biotherapeutics, Inc. (IOVA): Shareholders' Equity
$698.58M
As of 2025-12-31
$736.04M
As of 2026-06-30
+11.8%
3-year compound annual growth
+1.3%
5-year compound annual growth
+21.0%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $698.58M | -1.7% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $710.40M | +21.5% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $584.61M | +17.0% | 2026-02-24, Balance as of period end |
| 2022-12-31 | $499.64M | -19.6% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $621.66M | -5.3% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $656.50M | +119.6% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $298.97M | -35.9% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $466.19M | +220.4% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $145.48M | -12.8% | 2020-02-25, Balance as of period end |
| 2016-12-31 | $166.92M | +60.5% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $104.02M | +132.0% | 2018-03-12, Balance as of period end |
| 2014-12-31 | $44.84M | +154.8% | 2017-03-09, Balance as of period end |
| 2013-12-31 | $17.60M | n/m | 2016-03-11, Balance as of period end |
| 2012-12-31 | -$11.32M | n/m | 2014-03-28, Balance as of period end |
| 2011-12-31 | -$12.78M | n/m | 2014-03-28, Balance as of period end |
| 2010-12-31 | $638.1K | n/m | 2014-03-28, Balance as of period end |
| 2009-12-31 | -$13.5K | n/m | 2014-03-28, Balance as of period end |
| 2008-12-31 | $2.3K | n/a | 2014-03-28, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $698.58M | -1.7% |
| Vericel Corp (VCEL) | 2025-12-31 | $354.64M | +21.5% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $218.79M | +7.9% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $87.80M | +49.0% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $472.96M | +0.1% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $1.22B | +28.9% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $11.85M | -70.0% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $381.03M | +5.6% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $102.73M | -60.4% |
Compare IOVA, VCEL, ADPT, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗